The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koga, S.
Right arrow Articles by Fairchild, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koga, S.
Right arrow Articles by Fairchild, R. L.
The Journal of Immunology, 1999, 163: 4878-4885.
Copyright © 1999 by The American Association of Immunologists

T Cell Infiltration into Class II MHC-Disparate Allografts and Acute Rejection Is Dependent on the IFN-{gamma}-Induced Chemokine Mig1

Shoji Koga*, Michael B. Auerbach{dagger}, Tara M. Engeman{dagger}, Andrew C. Novick*, Hiroshi Toma§ and Robert L. Fairchild2,*,{dagger},{ddagger}

Departments of * Urology and {dagger} Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195; {ddagger} Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106; and § Department of Urology, Tokyo Women’s Medical School, Tokyo, Japan

Direct evidence that cytokines with chemoattractant properties for leukocytes, chemokines, recruit alloantigen-primed T cells into transplanted allografts has been lacking. We present evidence that neutralization of a single chemokine inhibits T cell infiltration into class II MHC-disparate murine allografts and acute rejection. The chemokines IFN-{gamma}-inducible protein-10 and monokine induced by IFN-{gamma} (Mig) are expressed in allogeneic skin grafts during the late stages of acute rejection. Survival of class II MHC-disparate B6.H-2bm12 allografts is prolonged from day 14 to day 55 posttransplant when C57BL/6 recipients are given a short course treatment with an antiserum to Mig. This treatment also inhibits T cell and macrophage infiltration into the allografts. B6.H-2bm12 allografts are also not rejected by IFN-{gamma}-/- C57BL/6 recipients. Injection of Mig directly into B6.H-2bm12 grafts on IFN-{gamma}-deficient recipients restores T cell infiltration and rejection. Therefore, the inability of IFN-{gamma}-deficient recipients to reject the class II MHC-disparate allografts is due to the lack of intraallograft Mig production and alloantigen-primed T cell recruitment to the graft. These results indicate for the first time the potential utility of chemokine neutralization strategies in preventing T cell infiltration into allografts and abrogating acute rejection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Schroder, R. N. Pierson III, B.-N. H. Nguyen, D. W. Kawka, L. B. Peterson, G. Wu, T. Zhang, M. S. Springer, S. J. Siciliano, S. Iliff, et al.
CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates
J. Immunol., August 15, 2007; 179(4): 2289 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. N. Mitchell and P. Libby
Vascular Remodeling in Transplant Vasculopathy
Circ. Res., April 13, 2007; 100(7): 967 - 978.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
X. Sun, H. P. Jones, L. M. Hodge, and J. W. Simecka
Cytokine and Chemokine Transcription Profile during Mycoplasma pulmonis Infection in Susceptible and Resistant Strains of Mice: Macrophage Inflammatory Protein 1{beta} (CCL4) and Monocyte Chemoattractant Protein 2 (CCL8) and Accumulation of CCR5+ Th Cells.
Infect. Immun., October 1, 2006; 74(10): 5943 - 5954.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yu, G. C. Sharp, and H. Braley-Mullen
Thyrocytes Responding to IFN-{gamma} Are Essential for Development of Lymphocytic Spontaneous Autoimmune Thyroiditis and Inhibition of Thyrocyte Hyperplasia
J. Immunol., January 15, 2006; 176(2): 1259 - 1265.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Amano, A. Bickerstaff, C. G. Orosz, A. C. Novick, H. Toma, and R. L. Fairchild
Absence of Recipient CCR5 Promotes Early and Increased Allospecific Antibody Responses to Cardiac Allografts
J. Immunol., May 15, 2005; 174(10): 6499 - 6508.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Schenk, D. D. Kish, C. He, T. El-Sawy, E. Chiffoleau, C. Chen, Z. Wu, S. Sandner, A. V. Gorbachev, K. Fukamachi, et al.
Alloreactive T Cell Responses and Acute Rejection of Single Class II MHC-Disparate Heart Allografts Are under Strict Regulation by CD4+CD25+ T Cells
J. Immunol., March 15, 2005; 174(6): 3741 - 3748.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. C. Hildebrandt, L. A. Corrion, K. M. Olkiewicz, B. Lu, K. Lowler, U. A. Duffner, B. B. Moore, W. A. Kuziel, C. Liu, and K. R. Cooke
Blockade of CXCR3 Receptor:Ligand Interactions Reduces Leukocyte Recruitment to the Lung and the Severity of Experimental Idiopathic Pneumonia Syndrome
J. Immunol., August 1, 2004; 173(3): 2050 - 2059.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Whiting, G. Hsieh, J. J. Yun, A. Banerji, W. Yao, M. C. Fishbein, J. Belperio, R. M. Strieter, B. Bonavida, and A. Ardehali
Chemokine Monokine Induced by IFN-{gamma}/CXC Chemokine Ligand 9 Stimulates T Lymphocyte Proliferation and Effector Cytokine Production
J. Immunol., June 15, 2004; 172(12): 7417 - 7424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. B. Sugerman, S. B. Faber, L. M. Willis, A. Petrovic, G. F. Murphy, J. Pappo, D. Silberstein, and M. R. M. van den Brink
Kinetics of Gene Expression in Murine Cutaneous Graft-versus-Host Disease
Am. J. Pathol., June 1, 2004; 164(6): 2189 - 2202.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. L. Colvin, A. E. Morelli, A. J. Logar, A. H. Lau, and A. W. Thomson
Comparative evaluation of CC chemokine-induced migration of murine CD8{alpha}+ and CD8{alpha}- dendritic cells and their in vivo trafficking
J. Leukoc. Biol., February 1, 2004; 75(2): 275 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. He, S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger
Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice
J. Immunol., January 1, 2004; 172(1): 240 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Belperio, M. P. Keane, M. D. Burdick, J. P. Lynch III, D. A. Zisman, Y. Y. Xue, K. Li, A. Ardehali, D. J. Ross, and R. M. Strieter
Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection
J. Immunol., November 1, 2003; 171(9): 4844 - 4852.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. L. Rabin, M. A. Alston, J. C. Sircus, B. Knollmann-Ritschel, C. Moratz, D. Ngo, and J. M. Farber
CXCR3 Is Induced Early on the Pathway of CD4+ T Cell Differentiation and Bridges Central and Peripheral Functions
J. Immunol., September 15, 2003; 171(6): 2812 - 2824.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q.-W. Zhang, D. D. Kish, and R. L. Fairchild
Absence of Allograft ICAM-1 Attenuates Alloantigen-Specific T Cell Priming, But Not Primed T Cell Trafficking into the Graft, to Mediate Acute Rejection
J. Immunol., June 1, 2003; 170(11): 5530 - 5537.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Jiankuo, W. Xingbing, H. Baojun, W. Xiongwin, L. Zhuoya, X. Ping, X. Yong, L. Anting, H. Chunsong, G. Feili, et al.
Peptide Nucleic Acid Antisense Prolongs Skin Allograft Survival by Means of Blockade of CXCR3 Expression Directing T Cells into Graft
J. Immunol., February 1, 2003; 170(3): 1556 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. T. Brice, N. L. Graber, D. J. Carucci, and D. L. Doolan
Optimal induction of antigen-specific CD8+ T cell responses requires bystander cell participation
J. Leukoc. Biol., December 1, 2002; 72(6): 1164 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. J. Yun, M. P. Fischbein, D. Whiting, Y. Irie, M. C. Fishbein, M. D. Burdick, J. Belperio, R. M. Strieter, H. Laks, J. A. Berliner, et al.
The Role of MIG/CXCL9 in Cardiac Allograft Vasculopathy
Am. J. Pathol., October 1, 2002; 161(4): 1307 - 1313.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. G. Inston and P. Cockwell
The evolving role of chemokines and their receptors in acute allograft rejection
Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1374 - 1379.
[Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Park, D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R. L. Rabin, H. H. Zhang, S. Gebeyehu, T. M. Wright, et al.
The CXC Chemokine Murine Monokine Induced by IFN-{gamma} (CXC Chemokine Ligand 9) Is Made by APCs, Targets Lymphocytes Including Activated B Cells, and Supports Antibody Responses to a Bacterial Pathogen In Vivo
J. Immunol., August 1, 2002; 169(3): 1433 - 1443.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Belperio, M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, K. Li, D. J. Ross, and R. M. Strieter
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome
J. Immunol., July 15, 2002; 169(2): 1037 - 1049.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-G. Yang, J. Qi, M.-G. Wang, and M. Sykes
Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells
Blood, May 13, 2002; 99(11): 4207 - 4215.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Dufour, M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster
IFN-{gamma}-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking
J. Immunol., April 1, 2002; 168(7): 3195 - 3204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Zhang, L. Kaptanoglu, W. Haddad, D. Ivancic, Z. Alnadjim, S. Hurst, D. Tishler, A. D. Luster, T. A. Barrett, and J. Fryer
Donor T Cell Activation Initiates Small Bowel Allograft Rejection Through an IFN-{gamma}-Inducible Protein-10-Dependent Mechanism
J. Immunol., April 1, 2002; 168(7): 3205 - 3212.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Fox-Marsh and L. C. Harrison
Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system
J. Leukoc. Biol., March 1, 2002; 71(3): 401 - 409.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Ganss, E. Ryschich, E. Klar, B. Arnold, and G. J. Hammerling
Combination of T-Cell Therapy and Trigger of Inflammation Induces Remodeling of the Vasculature and Tumor Eradication
Cancer Res., March 1, 2002; 62(5): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Miura, X. Fu, Q.-W. Zhang, D. G. Remick, and R. L. Fairchild
Neutralization of Gro{alpha} and Macrophage Inflammatory Protein-2 Attenuates Renal Ischemia/Reperfusion Injury
Am. J. Pathol., December 1, 2001; 159(6): 2137 - 2145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Guo, J. Wang, L. Meng, Q. Wu, O. Kim, J. Hart, G. He, P. Zhou, J. R. Thistlethwaite Jr., M.-L. Alegre, et al.
Cutting Edge: Membrane Lymphotoxin Regulates CD8+ T Cell-Mediated Intestinal Allograft Rejection
J. Immunol., November 1, 2001; 167(9): 4796 - 4800.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Wiseman, B. A. Pietra, B. P. Kelly, G. R. Rayat, M. Rizeq, and R. G. Gill
Donor IFN-{gamma} Receptors Are Critical for Acute CD4+ T Cell-Mediated Cardiac Allograft Rejection
J. Immunol., November 1, 2001; 167(9): 5457 - 5463.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Miura, K. Morita, H. Kobayashi, T. A. Hamilton, M. D. Burdick, R. M. Strieter, and R. L. Fairchild
Monokine Induced by IFN-{gamma} Is a Dominant Factor Directing T Cells into Murine Cardiac Allografts During Acute Rejection
J. Immunol., September 15, 2001; 167(6): 3494 - 3504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. F. Halloran, L. W. Miller, J. Urmson, V. Ramassar, L.-F. Zhu, N. M. Kneteman, K. Solez, and M. Afrouzian
IFN-{{gamma}} Alters the Pathology of Graft Rejection: Protection from Early Necrosis
J. Immunol., June 15, 2001; 166(12): 7072 - 7081.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Nakajima, Y. Uekusa, M. Iwasaki, N. Yamaguchi, T. Mukai, P. Gao, M. Tomura, S. Ono, T. Tsujimura, H. Fujiwara, et al.
A Role of Interferon-{{gamma}} (IFN-{{gamma}}) in Tumor Immunity: T Cells with the Capacity to Reject Tumor Cells Are Generated But Fail to Migrate to Tumor Sitesin IFN-{{gamma}}-deficient Mice
Cancer Res., April 1, 2001; 61(8): 3399 - 3405.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. K. Bishop, S. C. Wood, E. J. Eichwald, and C. G. Orosz
Immunobiology of Allograft Rejection in the Absence of IFN-{{gamma}}: CD8+ Effector Cells Develop Independently of CD4+ Cells and CD40-CD40 Ligand Interactions
J. Immunol., March 1, 2001; 166(5): 3248 - 3255.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Fox, J. Mountford, A. Braakhuis, and L. C. Harrison
Innate and Adaptive Immune Responses to Nonvascular Xenografts: Evidence That Macrophages Are Direct Effectors of Xenograft Rejection
J. Immunol., February 1, 2001; 166(3): 2133 - 2140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. F. Halloran, M. Afrouzian, V. Ramassar, J. Urmson, L.-F. Zhu, L. M. H. Helms, K. Solez, and N. M. Kneteman
Interferon-{{gamma}} Acts Directly on Rejecting Renal Allografts to Prevent Graft Necrosis
Am. J. Pathol., January 1, 2001; 158(1): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Sekine, K. Yasufuku, K. M. Heidler, O. W. Cummings, N. Van Rooijen, T. Fujisawa, J. Brown, and D. S. Wilkes
Monocyte Chemoattractant Protein-1 and RANTES Are Chemotactic for Graft Infiltrating Lymphocytes during Acute Lung Allograft Rejection
Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 719 - 726.
[Abstract] [Full Text]


Home page
JEMHome page
A. A. Ashkar, J. P. Di Santo, and B. A. Croy
Interferon {gamma} Contributes to Initiation of Uterine Vascular Modification, Decidual Integrity, and Uterine Natural Killer Cell Maturation during Normal Murine Pregnancy
J. Exp. Med., July 17, 2000; 192(2): 259 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. S. Diamond and R. G. Gill
An Essential Contribution by IFN-{gamma} to CD8+ T Cell-Mediated Rejection of Pancreatic Islet Allografts
J. Immunol., July 1, 2000; 165(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. P. Widney, Y.-R. Xia, A. J. Lusis, and J. B. Smith
The Murine Chemokine CXCL11 (IFN-Inducible T Cell {alpha} Chemoattractant) Is an IFN-{gamma}- and Lipopolysaccharide- Inducible Glucocorticoid-Attenuated Response Gene Expressed in Lung and Other Tissues During Endotoxemia
J. Immunol., June 15, 2000; 164(12): 6322 - 6331.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Watarai, S. Koga, D. R. Paolone, T. M. Engeman, C. Tannenbaum, T. A. Hamilton, and R. L. Fairchild
Intraallograft Chemokine RNA and Protein During Rejection of MHC-Matched/Multiple Minor Histocompatibility-Disparate Skin Grafts
J. Immunol., June 1, 2000; 164(11): 6027 - 6033.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.